Tag: SDG3

The TRIPS waiver on Covid-19 pharmaceuticals and the Big Pharma — IBON

June 4, 2021

Intellectual property rights (IPR) on essential drugs, most of which are being held by giant pharmaceutical corporations or “Big Pharma”, is a major issue when it comes to access to affordable, appropriate and efficacious essential medicines. At the highest echelons of international trade, the raging debate is about whether or not the World Trade Organization […]